Upperline Health Funding, Investors & Competitors

Upperline Health has raised $150M across 6 funding rounds, most recently a $12M Series A in February 2025.

Last Upperline Health funding round

$12M

Series A · Feb 2025

Cumulative funding Upperline Health raised

$150M

across 6 funding rounds

Key investors in Upperline Health

  • Silversmith Capital Partners
  • Crestline
  • Adam Boehler

Upperline Health Overview

About Upperline Health

Upperline Health is a Charlotte-headquartered platform building a nationwide network of podiatry clinics focused on foot and ankle care. It partners with over 100 independent practices across 20 states, delivering value-based services like diabetic foot management and surgical interventions. Since 2018, Upperline has treated more than 500,000 patients and secured contracts with payers covering 15 million lives.


Founded

2016

HQ

United StatesNashville, TN

Status

Privately held

Customer focus

B2B

Revenue model

Services, Subscription

Upperline Health Funding History

Upperline Health has raised a total of $150M across 6 funding rounds.

Upperline Health's first fundraising round was a $30M undisclosed-stage round in April 2018. The most recent completed round was a $12M Series A in February 2025.

Upperline Health funding rounds

Upperline Health funding rounds
DateStageInvestorsRaisedDeal Summary
Feb 2025Series A-$12M-
Jun 2023Undisclosed stageCrestline (lead); Adam Boehler; Silversmith Capital Partners$58MUpperline Health is the nation's largest provider network dedicated to specialty value-based care, focusing on podiatry and lower extremity care for patients with chronic conditions, operating 122 clinics across seven states: Alabama, California, Florida, Georgia, Indiana, Kentucky, and Tennessee. Founded in 2017 by former Aspire Health executives David Thorpe and Stephen Nash, the company serves 350,000 patients annually, has enrolled 30,000 patients in its Upperline Plus ACO REACH program for Medicare patients in recent months, reduced hospitalization spend by 30%, and achieved an 81/100 patient satisfaction score. It targets high-risk patients with chronic illnesses who have 3-5x average healthcare spend, providing comprehensive care through specialists, care navigators, pharmacists, social workers, and dieticians in clinics, homes, and via phone. In May 2023, Upperline Health closed a $58.35 million strategic capital raise led by Crestline Investors, with participation from existing investors Silversmith Capital Partners and Adam Boehler of Rubicon Founders, bringing total funding to $79 million. The round, advised by Silicon Valley Bank Securities, consisted of half debt and half equity, with Silversmith in the equity portion. Funds are earmarked to fuel growth in Upperline Plus, hire over 100 clinician, engineering, and management roles, enhance patient data analytics, and potentially pursue acquisitions after primarily organic expansion. The investment reflects confidence in Upperline's specialty-focused value-based care model amid limited VBC arrangements for specialists, who comprise 70% of providers. CEO David Thorpe noted the company is EBITDA positive, suggesting this could be its last funding round barring a future recap, with runway tied to growth pace. Upperline differentiates from home-based models like Landmark Health by emphasizing clinic-based specialist care and co-management with primary care physicians for disengaged, complex patients seen 4-6 times yearly.
May 2023Undisclosed stage-$28MUpperline Health, a Nashville-based provider network dedicated to specialty value-based care, closed a $58.35 million funding round in May 2023 led by Crestline Investors, with participation from existing investors Silversmith Capital Partners and Adam Boehler of Rubicon Founders. The round consisted of half debt and half equity, with total company funding to date reaching $79 million. The company was founded in 2017 by David Thorpe and Stephen Nash with the mission of providing comprehensive care to high-risk patient populations with chronic conditions, serving patients whose annual healthcare spend is 3-5 times the average. At the time of the funding announcement, Upperline Health operated 122 clinics across seven states (Alabama, California, Florida, Georgia, Indiana, Kentucky, and Tennessee) and served approximately 350,000 patients annually. The company had achieved significant clinical outcomes including a 30% reduction in hospitalization spend and an 81/100 patient satisfaction score. CEO David Thorpe indicated in interviews that the company was EBITDA positive at the time of the funding round, though specific EBITDA and revenue figures were not publicly disclosed. The capital was earmarked for expanding Upperline Plus, its Accountable Care Organization (ACO) REACH program serving Medicare patients, and for enhancing patient data collection and analysis capabilities.
Dec 2021Series A-$7M-
Feb 2020Series A-$14M-
Apr 2018Undisclosed stage-$30MUpperline Health is a Nashville-based provider network specializing in value-based care for patients with chronic conditions, particularly in podiatry and specialty care, founded in 2017 by David Thorpe and Stephen Nash. The company operates clinics across multiple states, focusing on high-risk patients through programs like Upperline Plus and ACO REACH, emphasizing treatment over triage with interdisciplinary care teams accessible via clinics, homes, or phone. It serves hundreds of thousands of patients annually and has demonstrated metrics such as 30% reduced hospitalization spend and high patient satisfaction scores. This earlier funding is noted in context of later rounds, with total funding reaching $79 million by 2023 after a $58.35 million raise led by Crestline Investors (half debt, half equity) involving Silversmith and Adam Boehler. The 2023 capital supported expansion of ACO programs, hiring, data analytics, and potential acquisitions, building on 300% year-over-year growth. Upperline Health was described as EBITDA positive in 2023, with 122 clinics in seven states serving 350,000 patients annually and enrolling 30,000 in Upperline Plus recently. The company has continued raising capital, including later rounds like Series D in 2025, reaching over $120 million total, amid a shift toward specialty value-based care models in healthcare.

Who has invested in Upperline Health?

3 investors have backed Upperline Health across its funding rounds, including Silversmith Capital Partners, Crestline and Adam Boehler.

Lead investors include Crestline.


Upperline Health Investors

Investors in Upperline Health by funding rounds participated
InvestorHQRoundsRoleFirst check
Adam BoehlerUnited StatesNashville, TN1ParticipantJun 2023

This data is available for Pro users. Sign up to see all 3 Upperline Health investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Upperline Health Competitors

Upperline Health competitors include listed companies like IQVIA and Veeva, and private ones like Cityblock Health, Aledade, Somatus and Strive Health.

Public and private companies comparable to Upperline Health
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Cityblock HealthUnited StatesNew York City, NYPrivate--$5.7B-
AledadeUnited StatesWashington, DCPrivate$475M-$3.5B7.4x
SomatusUnited StatesWashington, DCPrivate--$2.5B-
Strive HealthUnited StatesDenver, COPrivate--$1.8B-
IQVIAUnited StatesUnited StatesPublicly listed$16B$3.4B$44B3.4x
VeevaUnited StatesUnited StatesPublicly listed$3.2B$965M$43B10.2x

Upperline Health Public Comps

Upperline Health is still privately-owned, but its public comps include UnitedHealth Group, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging and Molina Healthcare.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
UnitedHealth Group$448B$23B0.9x0.9x16.7x13.3x
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Veeva$3.2B$965M11.1x10.2x36.9x22.4x
IDEXX Laboratories$4.3B$1.5B9.5x8.9x27.1x24.9x
Roper Technologies$7.9B$3.2B6.1x5.7x15.2x14.6x
GE HealthCare$21B$3.7B1.8x1.8x10.1x10.0x
ICON plc$8.3B$816M1.9x1.9x19.2x11.3x
Pro Medicus$186M$147M66.6x62.7x84.4x77.6x

This data is available for Pro users. Sign up to see all Upperline Health competitors and their valuation data.

Start Free Trial

Common questions about Upperline Health

When was Upperline Health founded?Upperline Health was founded in 2016.
Where is Upperline Health headquartered?Upperline Health is headquartered in Nashville, TN, United States.
Is Upperline Health publicly listed?No, Upperline Health is a private, VC-backed company.
How much funding has Upperline Health raised?Upperline Health has raised $150M across 6 funding rounds.
What was Upperline Health's last funding round?Upperline Health's last funding round was a $12M Series A in February 2025.
Who are Upperline Health's investors?Upperline Health's investors include Adam Boehler, Crestline and Silversmith Capital Partners.
Which companies are comparable to Upperline Health?Companies comparable to Upperline Health include Cityblock Health, Aledade, Somatus, Strive Health, IQVIA and Veeva.

See companies similar to Upperline Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial